JPH04316531A - Cyclohexanone derivative - Google Patents

Cyclohexanone derivative

Info

Publication number
JPH04316531A
JPH04316531A JP3246561A JP24656191A JPH04316531A JP H04316531 A JPH04316531 A JP H04316531A JP 3246561 A JP3246561 A JP 3246561A JP 24656191 A JP24656191 A JP 24656191A JP H04316531 A JPH04316531 A JP H04316531A
Authority
JP
Japan
Prior art keywords
formula
hydrogen atom
compound
group
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3246561A
Other languages
Japanese (ja)
Other versions
JP3241760B2 (en
Inventor
Paul H Briner
ポール・ハワード・ブリナー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shell Internationale Research Maatschappij BV
Original Assignee
Shell Internationale Research Maatschappij BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909019193A external-priority patent/GB9019193D0/en
Priority claimed from GB909019192A external-priority patent/GB9019192D0/en
Priority claimed from GB909019194A external-priority patent/GB9019194D0/en
Application filed by Shell Internationale Research Maatschappij BV filed Critical Shell Internationale Research Maatschappij BV
Publication of JPH04316531A publication Critical patent/JPH04316531A/en
Application granted granted Critical
Publication of JP3241760B2 publication Critical patent/JP3241760B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C07C45/292—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with chromium derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/58—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in three-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/687—Unsaturated compounds containing a keto groups being part of a ring containing halogen
    • C07C49/697—Unsaturated compounds containing a keto groups being part of a ring containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)

Abstract

PURPOSE: To provide a novel cyclohexanone deriv. useful as an intermediate for a cyclopentane deriv. having sterilizing activity.
CONSTITUTION: The compd. of formula I ((n) is an integer from 0 to 5; respective R are halogen, NO2, CN., OH, alkyl, haloalkyl, alkoxy, haloalkoxy, NH2, mono-dialkylamino, alkoxycarbonyl, COOH, alkanoyl, alkylthio, alkylsulfinyl, alkylsulfonyl, CONH2, alkylamide, cycloalkyl, phenyl, R1 to R3 are H, alkyl; R6, R7 are, together, a single C-C bond or epoxy; R8 is H, OH, when R6 and R7 are epoxy, R8 is H); for example, 1-C4-chlorbenzyl)-4,4-dimethylcyclohexy-1- ene-3-one. The compd. in which R8 is H is obtd. by bringing the compd. of formula II into reaction with an oxidizing agent in the presence of an acid, then bringing the product into reaction with hydrogen peroxide in the presence of a base it desired.
COPYRIGHT: (C)1992,JPO

Description

【発明の詳細な説明】[Detailed description of the invention]

【0001】本発明は、殺菌活性シクロペンタン誘導体
の製造に際し中間体として有用である或る種のシクロヘ
キサノン誘導体およびその製造方法に関するものである
。
The present invention relates to certain cyclohexanone derivatives that are useful as intermediates in the production of fungicidally active cyclopentane derivatives, and to processes for their production.

【0002】本発明によれば、一般式:According to the invention, the general formula:

【化3】 〔式中、nは0〜5の整数を示し;  各Rはハロゲン
原子、ニトロ、シアノ、ヒドロキシル、アルキル、ハロ
アルキル、アルコキシ、ハロアルコキシ、アミノ、アル
キルアミノ、ジアルキルアミノ、アルコキシカルボニル
、カルボキシル、アルカノイル、アルキルチオ、アルキ
ルスルフィニル、アルキルスルホニル、カルバモイル、
アルキルアミド、シクロアルキルもしくはフェニル基を
示し;  R1 、R2 およびR3 は独立して水素
原子もしくはアルキル基を示し;  R6 およびR7
 は一緒になって単一の炭素−炭素結合またはエポキシ
基を示し;  R8 は水素原子もしくはヒドロキシル
基を示し;  ただしR6 とR7とが一緒になってエ
ポキシ基を示せばR8 は水素原子を示す〕の化合物が
提供される。
[Formula, n represents an integer of 0 to 5; each R is a halogen atom, nitro, cyano, hydroxyl, alkyl, haloalkyl, alkoxy, haloalkoxy, amino, alkylamino, dialkylamino, alkoxycarbonyl, carboxyl, alkanoyl, alkylthio, alkylsulfinyl, alkylsulfonyl, carbamoyl,
represents an alkylamide, cycloalkyl or phenyl group; R1, R2 and R3 independently represent a hydrogen atom or an alkyl group; R6 and R7
together represent a single carbon-carbon bond or an epoxy group; R8 represents a hydrogen atom or a hydroxyl group; however, if R6 and R7 together represent an epoxy group, R8 represents a hydrogen atom] A compound is provided.

【0003】上記置換基のいずれかがアルキル置換基を
示し或いは含む場合、これは直鎖もしくは分枝鎖とする
ことができ、12個まで、好ましくは6個まで、特に4
個までの炭素原子を有することができる。シクロアルキ
ル置換基は3〜8個、好ましくは3〜6個の炭素原子を
有することができる。R1 、R2 およびR3 は独
立して水素原子またはC1−4 アルキル、特にメチル
基を示すことが好ましい。好ましくは、Rはハロゲン、
特に塩素原子を示す。式Iの特に好適な化合物の種類は
nが1であり、Rが塩素原子(好ましくはフェニル環の
4−位置にて置換される)を示し、R1 およびR2 
が両者とも水素原子を示し或いは両者ともメチル基を示
し、R3 が水素原子もしくはメチル基を示すものであ
る。
If any of the above substituents represents or contains an alkyl substituent, this can be straight-chain or branched and contains up to 12, preferably up to 6, especially 4
It can have up to 2 carbon atoms. Cycloalkyl substituents can have 3 to 8, preferably 3 to 6 carbon atoms. It is preferable that R1, R2 and R3 independently represent a hydrogen atom or a C1-4 alkyl group, particularly a methyl group. Preferably, R is halogen,
Specifically indicates a chlorine atom. A particularly preferred class of compounds of formula I is in which n is 1, R represents a chlorine atom (preferably substituted in the 4-position of the phenyl ring), and R1 and R2
Both represent a hydrogen atom or both represent a methyl group, and R3 represents a hydrogen atom or a methyl group.

【0004】さらに本発明は、上記式Iの化合物の製造
方法をも提供し、この方法は(a)一般式:
The present invention further provides a method for preparing a compound of formula I above, which method comprises (a) the general formula:

【化4】 〔式中、n、R、R1 、R2 およびR3 は上記の
意味を有する〕の化合物を酸化剤と反応させて、R6 
とR7 とが一緒になって単一の炭素−炭素結合を示し
かつR8 が水素原子を示す式Iの化合物を生成させ;
[Image Omitted] A compound of [Formula n, R, R1, R2 and R3 have the above meanings] is reacted with an oxidizing agent to form R6
and R7 together represent a single carbon-carbon bond and R8 represents a hydrogen atom;

【0005】(b)所望ならば、工程(a)で生成され
た式Iの化合物を塩基の存在下に過酸化水素と反応させ
て、R6 とR7 とが一緒になってエポキシ基を示し
かつR8 が水素原子を示す式Iの化合物を生成させ;
(c)所望ならば、工程(b)で生成された式Iの化合
物を極性溶剤の存在下に一般式: MOR5                     
  (III)〔式中、R5 は水素原子またはアルキ
ル、好ましくはC1−6 第三アルキル、特にC4−6
 第三アルキル、もしくはシクロアルキル、好ましくは
C3−6 シクロアルキル基を示し、Mはアルカリ金属
、好ましくはナトリウムもしくはカリウム原子を示す〕
の化合物と反応させて、R6 とR7 とが一緒になっ
て単一の炭素−炭素結合を示しかつR8 がヒドロキシ
ル基を示す式Iの化合物を生成させることを特徴とする
。
(b) If desired, the compound of formula I produced in step (a) is reacted with hydrogen peroxide in the presence of a base so that R6 and R7 together represent an epoxy group and producing a compound of formula I in which R8 represents a hydrogen atom;
(c) If desired, the compound of formula I produced in step (b) is dissolved in the presence of a polar solvent to the general formula: MOR5
(III) [wherein R5 is a hydrogen atom or alkyl, preferably C1-6 tertiary alkyl, especially C4-6
represents a tertiary alkyl or cycloalkyl group, preferably a C3-6 cycloalkyl group, and M represents an alkali metal, preferably a sodium or potassium atom]
to form compounds of formula I in which R6 and R7 together represent a single carbon-carbon bond and R8 represents a hydroxyl group.

【0006】好ましくは、工程(a)における酸化剤は
クロム(VI)塩、たとえばアルカリ金属重クロム酸塩
、特に重クロム酸ナトリウムまたは重クロム酸カリウム
である。酸化剤としてアルカリ金属重クロム酸塩を使用
する場合、反応は好ましくは酸の存在下に行なわれる。 さらに、酸を希鉱酸とするのが好ましく、希硫酸が特に
好適である。工程(a)は便利には溶剤の存在下に行な
うことができる。適する溶剤はエーテル、たとえばジエ
チルエーテルを包含する。或いは、酸は溶剤として作用
することもできる。反応は、好適には0〜70℃、好ま
しくは10〜60℃の範囲の温度で行なわれる。
Preferably, the oxidizing agent in step (a) is a chromium (VI) salt, such as an alkali metal dichromate, especially sodium or potassium dichromate. When using alkali metal dichromates as oxidizing agents, the reaction is preferably carried out in the presence of an acid. Furthermore, it is preferred that the acid is a dilute mineral acid, with dilute sulfuric acid being particularly preferred. Step (a) may conveniently be carried out in the presence of a solvent. Suitable solvents include ethers such as diethyl ether. Alternatively, the acid can act as a solvent. The reaction is suitably carried out at a temperature ranging from 0 to 70°C, preferably from 10 to 60°C.

【0007】好ましくは、工程(b)における塩基は無
機塩基、たとえば水酸化ナトリウム、水酸化カリウムま
たは第四水酸化アンモニウムである。工程(b)は、便
利には溶剤の存在下に行なうことができる。適する溶剤
はアルコール、たとえばメタノール、エタノール、特に
t−ブタノールを包含する。好適には反応は−10〜6
0℃、好ましくは0〜50℃の範囲の温度で行なわれる
。工程(c)における極性溶剤はアルコール、好ましく
はC1−6 、特にC4−6 第三級アルコールである
ことが好ましい。溶剤としてアルコールを使用する場合
、アルコールにおけるアルキル部分は式III の化合
物におけるR5 と同じであることが好ましい。たとえ
ば式III の化合物がカリウムt−ブトキシドであれ
ば、アルコールはt−ブタノールであることが好ましい
。反応は、便利には30℃〜溶剤の還流温度の範囲の温
度で行なわれる。
Preferably, the base in step (b) is an inorganic base, such as sodium hydroxide, potassium hydroxide or quaternary ammonium hydroxide. Step (b) may conveniently be carried out in the presence of a solvent. Suitable solvents include alcohols such as methanol, ethanol and especially t-butanol. Preferably the reaction is -10 to 6
It is carried out at a temperature in the range of 0°C, preferably 0 to 50°C. Preferably, the polar solvent in step (c) is an alcohol, preferably a C1-6, especially a C4-6 tertiary alcohol. When alcohol is used as the solvent, it is preferred that the alkyl moiety in the alcohol is the same as R5 in the compound of formula III. For example, if the compound of formula III is potassium t-butoxide, the alcohol is preferably t-butanol. The reaction is conveniently carried out at a temperature ranging from 30°C to the reflux temperature of the solvent.

【0008】式IIの化合物は、便利には式:Compounds of formula II are conveniently of the formula:

【化5】 〔式中、R1 、R2 およびR3 は上記の意味を有
する〕の化合物を一般式:
[Image Omitted] A compound of [wherein R1, R2 and R3 have the above meanings] is represented by the general formula:

【化6】 〔式中、Rおよびnは上記の意味を有し、Lは有機金属
基、たとえばリチウムまたは基−MgHal(ここでH
alは塩素もしくは臭素原子を示す)を示す〕の化合物
と反応させて製造することができる。式IIの化合物お
よびその製造方法は、本出願人による特許出願T689
の主題を形成する。式 III、IVおよびVの化合物
は公知化合物であるか、或いは公知方法と類似した方法
により製造することができる。
embedded image where R and n have the above meanings and L is an organometallic group, such as lithium or a group -MgHal (where H
al represents a chlorine or bromine atom)]. Compounds of formula II and methods for their preparation are described in patent application T689 by the applicant.
form the subject of. Compounds of formulas III, IV and V are known compounds or can be prepared by methods analogous to known methods.

【0009】式Iの化合物は、一般式:Compounds of formula I have the general formula:

【化7】 〔式中、n、R、R1 、R2 およびR3 は上記の
意味を有し、Aは窒素原子もしくはCH基を示す〕の殺
菌活性シクロペンタン誘導体を製造する際の中間体とし
て有用である。式VIの或る種の化合物は、本出願人に
よる特許出願GB−A1−2180236号およびEP
−A2−0267778号の主題である。EP−A2−
0267778号およびGB−A1−2180236号
に開示された化合物は2種の立体異性型で存在し、次の
構造を有する:
Useful as an intermediate in the production of bactericidal cyclopentane derivatives [wherein n, R, R1, R2 and R3 have the above meanings, and A represents a nitrogen atom or a CH group] It is. Certain compounds of formula VI are described in patent applications GB-A1-2180236 and EP
-A2-0267778. EP-A2-
The compounds disclosed in Nos. 0267778 and GB-A1-2180236 exist in two stereoisomeric forms and have the following structures:

【0010】0010

【化8】[Chemical formula 8]

【化9】[Chemical formula 9]

【0011】以下、記号AおよびBは、上記異性体Aお
よびBと同じ立体化学配置を有する化合物を示すために
使用される。異性体AおよびBはたとえばクロマトグラ
フィーによって分離することができ、異なる殺菌活性を
示す。一般に、式VIAの異性体は式VIBの異性体よ
りも大きい殺菌活性を示す。R6 とR7 とが一緒に
なって単一の炭素−炭素結合を示しかつR8 がヒドロ
キシル基を示す式Iの化合物から式VIAの化合物を合
成するために使用する方法を以下の反応式で示す:
In the following, the symbols A and B are used to indicate compounds having the same stereochemical configuration as isomers A and B above. Isomers A and B can be separated, for example by chromatography, and exhibit different fungicidal activities. Generally, isomers of formula VIA exhibit greater fungicidal activity than isomers of formula VIB. The method used to synthesize compounds of formula VIA from compounds of formula I where R6 and R7 together represent a single carbon-carbon bond and R8 represents a hydroxyl group is illustrated in the following reaction scheme:

【0012】0012

【化10】[Chemical formula 10]

【0013】上記反応式においてn、R、R1 、R2
 、R3 、R5 、MおよびAは上記の意味を有し、
R4 は適宜置換されたアルキルもしくはアリール基、
好ましくはC1−4 アルキルもしくはフェニル基を示
し、それぞれ必要に応じハロゲン原子、ニトロ、シアノ
、ヒドロキシル、C1−4 アルキル、C1−4 ハロ
アルキル、C1−4 アルコキシ、C1−4 ハロアル
コキシ、アミノ、C1−4 アルキルアミノ、ジ−C1
−4 アルキルアミノ、C1−4 アルコキシカルボニ
ル、カルボキシル、C1−4 アルカノイル、C1−4
 アルキルチオ、C1−4 アルキルスルフィニル、C
1−4 アルキルスルホニル、カルバモイル、C1−4
 アルキルアミド、C3−8 シクロアルキルおよびフ
ェニル基から選択される1個もしくはそれ以上の置換基
により置換され、Xはハロゲン、好ましくは塩素もしく
は臭素原子を示し、Qは水素もしくはアルカリ金属、好
ましくはナトリウムもしくはカリウム原子を示す。上記
反応式における中間化合物および工程は、本出願人によ
る特許出願T693、ヨーロッパ特許出願第89202
159.3号および英国特許出願第8820607.3
号の主題である。
In the above reaction formula, n, R, R1, R2
, R3, R5, M and A have the above meanings,
R4 is an appropriately substituted alkyl or aryl group,
Preferably it represents a C1-4 alkyl or phenyl group, and if necessary, a halogen atom, nitro, cyano, hydroxyl, C1-4 alkyl, C1-4 haloalkyl, C1-4 alkoxy, C1-4 haloalkoxy, amino, C1- 4 alkylamino, di-C1
-4 alkylamino, C1-4 alkoxycarbonyl, carboxyl, C1-4 alkanoyl, C1-4
Alkylthio, C1-4 alkylsulfinyl, C
1-4 alkylsulfonyl, carbamoyl, C1-4
substituted by one or more substituents selected from alkylamides, C3-8 cycloalkyl and phenyl groups, X represents a halogen, preferably a chlorine or bromine atom, and Q represents hydrogen or an alkali metal, preferably sodium Or indicates a potassium atom. The intermediate compounds and steps in the above reaction formula are described in patent application T693 and European patent application No. 89202 by the applicant.
No. 159.3 and UK Patent Application No. 8820607.3
This is the subject of the issue.

【0014】以下、実施例により本発明をさらに説明す
る。 実施例1 1−(4−クロルベンジル)−4,4−ジメチルシクロ
ヘキシ−1−エン−3−オンの製造 (n=1、  R=4−Cl、  R1 =R2 =C
H3 、  R3 =H、  R6 およびR7 =単
一C−C結合、  R8 =H) (a)1−(4−クロルベンジル)−4,4−ジメチル
シクロヘキシ−2−エン−1−オールの製造ジエチルエ
ーテル(200ml)における塩化4−クロルベンジル
(266g、1.65モル)の溶液を、ジエチルエーテ
ル(700ml)におけるマグネシウム(42g、1.
73モル)の攪拌混合物にゆっくり添加して混合物を還
流状態に維持した。この混合物を、添加が完了した後、
さらに20分間加温した。次いで、ジエチルエーテル(
60ml)における4,4−ジメチルシクロヘキシ−2
−エン−1−オン(226g、1.82モル)の溶液を
30分間かけて滴下し、混合物を還流状態に維持すると
共に混合物を1晩攪拌した。次いで、混合物を水(25
0ml)および塩酸(5M、500ml)で反応停止さ
せ、ジエチルエーテル(3×400ml)で抽出し、重
炭酸ナトリウム溶液(5%w/v)にて1回および水で
1回逆洗し、次いで無水硫酸マグネシウムで脱水した。 次いで溶剤をフラッシュ除去して369gの1−(4−
クロルベンジル)−4,4−ジメチルシクロヘキシ−2
−エン−1−オールを油状物として得た。 NMR(CDCl3 溶剤中、基準としてテトラメチル
シラン)特性ピーク:δ(ppm)    0.90、
0.99(3H、シングレット)、2.78(2H、シ
ングレット)、  5.40(1H、ダブレット、J=
11Hz)、  5.50(1H、ダブレット、J=1
1Hz)、  7.17(2H、ダブレット、J=8H
z)、  7.26(2H、ダブレット、J=8Hz)
。
The present invention will be further explained below with reference to Examples. Example 1 Production of 1-(4-chlorobenzyl)-4,4-dimethylcyclohex-1-en-3-one (n=1, R=4-Cl, R1=R2=C
H3, R3 = H, R6 and R7 = single C-C bond, R8 = H) (a) Preparation of 1-(4-chlorobenzyl)-4,4-dimethylcyclohex-2-en-1-ol A solution of 4-chlorobenzyl chloride (266 g, 1.65 mol) in diethyl ether (200 ml) was dissolved in magnesium (42 g, 1.6 mol) in diethyl ether (700 ml).
73 mol) was added slowly to the stirred mixture to maintain the mixture at reflux. After the addition is complete, add this mixture to
The mixture was further heated for 20 minutes. Then diethyl ether (
4,4-dimethylcyclohexy-2 in 60 ml)
A solution of -en-1-one (226 g, 1.82 mol) was added dropwise over 30 minutes, the mixture was maintained at reflux and the mixture was stirred overnight. The mixture was then diluted with water (25
0 ml) and hydrochloric acid (5M, 500 ml), extracted with diethyl ether (3 x 400 ml), backwashed once with sodium bicarbonate solution (5% w/v) and once with water, then Dehydrated with anhydrous magnesium sulfate. The solvent was then flashed off and 369 g of 1-(4-
Chlorbenzyl)-4,4-dimethylcyclohexy-2
-en-1-ol was obtained as an oil. NMR (in CDCl3 solvent, tetramethylsilane as reference) Characteristic peak: δ (ppm) 0.90,
0.99 (3H, singlet), 2.78 (2H, singlet), 5.40 (1H, doublet, J=
11Hz), 5.50 (1H, doublet, J=1
1Hz), 7.17 (2H, doublet, J=8H
z), 7.26 (2H, doublet, J=8Hz)
.

【0015】(b)1−(4−クロルベンジル)−4,
4−ジメチルシクロヘキシ−1−エン−3−オンの製造
40/60石油(40ml)における工程(a)で得ら
れた1−(4−クロルベンジル)−4,4−ジメチルシ
クロヘキシ−2−エン−1−オール(368g、1.4
7モル)の溶液を、一定の流れとして、希硫酸(250
g、2.6モル、水1.5リットルにおける98%硫酸
)における重クロム酸ナトリウム(217g、0.74
モル)の溶液に添加した。次いで反応混合物を10〜3
0℃の温度に保ち、40分間攪拌した。水(500ml
)とジエチルエーテル(700ml)とを添加し、水層
をジエチルエーテル(2×700ml)で2回抽出した
。 次いで有機相を合し、飽和重炭酸ナトリウム溶液(1×
500ml)と水(1×500ml)とで逆洗した。次
いで溶剤をフラッシュ除去して、349gの粗製1−(
4−クロルベンジル)−4,4−ジメチルシクロヘキシ
−1−エン−3−オンをベージュ色の粒状固体として得
た。 石油におけるトリチル化は所望生成物の純粋試料を与え
た。融点87〜90℃。
(b) 1-(4-chlorobenzyl)-4,
Preparation of 4-dimethylcyclohex-1-en-3-one 1-(4-chlorobenzyl)-4,4-dimethylcyclohexy-2- obtained in step (a) in 40/60 petroleum (40 ml) En-1-ol (368g, 1.4
A solution of 7 mol) of dilute sulfuric acid (250
Sodium dichromate (217 g, 0.74 g, 2.6 mol, 98% sulfuric acid in 1.5 liters of water)
molar) solution. The reaction mixture was then diluted with 10-3
The temperature was maintained at 0° C. and stirred for 40 minutes. Water (500ml
) and diethyl ether (700ml) were added and the aqueous layer was extracted twice with diethyl ether (2 x 700ml). The organic phases were then combined and saturated sodium bicarbonate solution (1×
500 ml) and water (1 x 500 ml). The solvent was then flashed off to give 349 g of crude 1-(
4-chlorobenzyl)-4,4-dimethylcyclohex-1-en-3-one was obtained as a beige granular solid. Tritylation in petroleum gave pure samples of the desired product. Melting point 87-90°C.

【0016】実施例2 1−(4−クロルベンジル)−1,2−エポキシ−4,
4−ジメチルシクロヘキサン−3−オンの製造(n=1
、  R=4−Cl、  R1 =R2 =CH3 、
  R3 =H、  R6 およびR7 =−O−、 
 R8 =H)上記実施例1に記載したように得られた
1726g(6.945モル)の粗製1−(4−クロル
ベンジル)−4,4−ジメチルシクロヘキシ−1−エン
−3−オンとエタノール(8630ml)とを20リッ
トルの反応器に充填し、40℃まで加温して透明な淡橙
色溶液を得た。次いで反応混合物を18℃まで冷却し、
20%(w/v)の水酸化ナトリウム(650ml)を
冷却(氷/水)しながらゆっくり添加して、この温度を
維持した。 反応混合物を11〜20℃の温度に保ちながら30%(
w/v)の過酸化水素水溶液(794ml、7モル)を
1時間かけて添加し、次いで混合物を1晩攪拌した。次
いで水(16リットル)を氷冷しながら添加し、反応混
合物を15分間攪拌した。遠心分離に続き水(4×2.
5リットル)で洗浄してオフホワイト色の固体を得、こ
れを次いで風乾して1634gの1−(4−クロルベン
ジル)−1,2−エポキシ−4,4−ジメチルシクロヘ
キサン−3−オンを得た。融点69〜70℃。
Example 2 1-(4-chlorobenzyl)-1,2-epoxy-4,
Production of 4-dimethylcyclohexan-3-one (n=1
, R=4-Cl, R1=R2=CH3,
R3 = H, R6 and R7 = -O-,
R8 = H) 1726 g (6.945 mol) of crude 1-(4-chlorobenzyl)-4,4-dimethylcyclohex-1-en-3-one obtained as described in Example 1 above and A 20-liter reactor was charged with ethanol (8630 ml) and heated to 40° C. to obtain a clear pale orange solution. The reaction mixture was then cooled to 18°C,
20% (w/v) sodium hydroxide (650ml) was added slowly with cooling (ice/water) to maintain this temperature. 30% (
Aqueous hydrogen peroxide (794 ml, 7 mol) w/v) was added over 1 hour and the mixture was stirred overnight. Water (16 liters) was then added with ice cooling and the reaction mixture was stirred for 15 minutes. Centrifugation followed by water (4 x 2.
5 liters) to give an off-white solid, which was then air dried to give 1634 g of 1-(4-chlorobenzyl)-1,2-epoxy-4,4-dimethylcyclohexan-3-one. Ta. Melting point 69-70°C.

【0017】実施例3 1−(4−クロルベンジル)−2−ヒドロキシ−4,4
−ジメチルシクロヘキシ−1−エン−3−オンの製造(
n=1、  R=4−Cl、  R1 =R2 =CH
3 、  R3 =H、  R6 およびR7 =単一
C−C結合、  R8 =OH) 上記実施例2で得られた38.7g(146ミリモル)
の1−(4−クロルベンジル)−1,2−エポキシ−4
,4−ジメチルシクロヘキサン−3−オンを、t−ブタ
ノール(200ml)におけるカリウムt−ブトキシド
(33g、294ミリモル)のスラリーに40℃にて添
加した。この混合物を次いで60℃まで加温し、かつ2
時間攪拌した後に氷で冷却すると共に水(50ml)で
反応停止させた。次いで5Mの塩酸(100ml)を徐
々に添加し、次いで水(300ml)を添加した。次い
で混合物を0℃まで冷却し、濾過し、残留物を水(10
0ml)で洗浄した。40℃にて減圧下に乾燥すること
により36.3gの1−(4−クロルベンジル)−2−
ヒドロキシ−4,4−ジメチルシクロヘキシ−1−エン
−3−オンを得た。融点80〜82℃。
Example 3 1-(4-chlorobenzyl)-2-hydroxy-4,4
-Production of dimethylcyclohex-1-en-3-one (
n=1, R=4-Cl, R1=R2=CH
3, R3 = H, R6 and R7 = single C-C bond, R8 = OH) 38.7 g (146 mmol) obtained in Example 2 above
1-(4-chlorobenzyl)-1,2-epoxy-4
,4-dimethylcyclohexan-3-one was added to a slurry of potassium t-butoxide (33 g, 294 mmol) in t-butanol (200 ml) at 40<0>C. The mixture was then warmed to 60°C and
After stirring for an hour, the mixture was cooled with ice and the reaction was stopped with water (50 ml). 5M hydrochloric acid (100ml) was then added slowly followed by water (300ml). The mixture was then cooled to 0°C, filtered and the residue was diluted with water (10
0 ml). By drying under reduced pressure at 40°C, 36.3 g of 1-(4-chlorobenzyl)-2-
Hydroxy-4,4-dimethylcyclohex-1-en-3-one was obtained. Melting point: 80-82°C.

【0018】実施例4 1−(4−クロルベンジル)−4,4,6−トリメチル
シクロヘキシ−1−エン−3−オンの製造(n=1、 
 R=4−Cl、  R1 =R2 =R3 =CH3
 、  R6 およびR7 =単一C−C結合、  R
8 =H)(a)1−(4−クロルベンジル)−4,4
,6−トリメチルシクロヘキシ−2−エン−1−オール
の製造ジエチルエーテル(300ml)におけるマグネ
シウム切屑(66g、2.73グラム原子)のスラリー
に、ジエチルエーテル(1500ml)における塩化4
−クロルベンジル(418g、2.6モル)の溶液を、
緩和な還流を維持するような速度で添加した。さらに3
0分間の後、ジエチルエーテル(350ml)における
4,4,6−トリメチルシクロヘキシ−2−エン−1−
オン(340g、2.46モル)の溶液を添加し、再び
緩和な還流を維持した。1時間の後、混合物を飽和塩化
アンモニウム水溶液(4リットル)中に添加し、相を分
離させた。 エーテル相を水(1リットル)で逆洗し、これを直接に
次の反応に使用した。1−(4−クロルベンジル)−4
,4,6−トリメチルシクロヘキシ−2−エン−1−オ
ールの小部分を単離して特性化した(ガスクロマトグラ
フィー分析は、ほぼ等しい量における2種の異性体を示
した)。 NMR(CDCl3 溶剤中、基準としてテトラメチル
シラン)特性ピーク:δ(ppm)    0.75、
0.95、1.00、1.02、1.05、1.07、
1.09(全9H)、  2.00(1H、マルチプレ
ット)、  2.57、2.79(2H、AB、J=1
2Hz)、  2.69、2.94(2H、AB、J=
12Hz)、  4.94(1H、ダブレット、J=1
0Hz)、  5.34(1H、ダブレット、J=10
Hz)、7.1−7.4(4H)。
Example 4 Preparation of 1-(4-chlorobenzyl)-4,4,6-trimethylcyclohex-1-en-3-one (n=1,
R=4-Cl, R1=R2=R3=CH3
, R6 and R7 = single C-C bond, R
8 = H) (a) 1-(4-chlorobenzyl)-4,4
Preparation of , 6-trimethylcyclohex-2-en-1-ol A slurry of magnesium shavings (66 g, 2.73 gram atoms) in diethyl ether (300 ml) was treated with 4 chloride in diethyl ether (1500 ml).
- a solution of chlorobenzyl (418 g, 2.6 mol),
Addition was made at a rate to maintain mild reflux. 3 more
After 0 min, 4,4,6-trimethylcyclohex-2-ene-1- in diethyl ether (350 ml)
(340 g, 2.46 mol) was added and again a mild reflux was maintained. After 1 hour, the mixture was added to saturated aqueous ammonium chloride solution (4 liters) and the phases were separated. The ether phase was backwashed with water (1 liter) and used directly in the next reaction. 1-(4-chlorobenzyl)-4
, 4,6-trimethylcyclohex-2-en-1-ol was isolated and characterized (gas chromatographic analysis showed the two isomers in approximately equal amounts). NMR (in CDCl3 solvent, tetramethylsilane as reference) Characteristic peak: δ (ppm) 0.75,
0.95, 1.00, 1.02, 1.05, 1.07,
1.09 (all 9H), 2.00 (1H, multiplet), 2.57, 2.79 (2H, AB, J=1
2Hz), 2.69, 2.94 (2H, AB, J=
12Hz), 4.94 (1H, doublet, J=1
0Hz), 5.34 (1H, doublet, J=10
Hz), 7.1-7.4 (4H).

【0019】(b)1−(4−クロルベンジル)−4,
4,6−トリメチルシクロヘキシ−1−エン−3−オン
の製造 希硫酸(428g、水2.5リットルにおける98%硫
酸)における重クロム酸ナトリウム(281g、0.9
43モル)の溶液を、工程(a)で得られた1−(4−
クロルベンジル)−4,4,6−トリメチルシクロヘキ
シ−2−エン−1−オールのエーテル溶液に添加した。 次いで反応混合物を50〜60℃まで3〜4時間かけて
加熱し、次いで冷却し、水(2リットル)およびジエチ
ルエーテル(1リットル)で反応停止させた。相を分離
させ、有機相を20%(w/v)の水酸化ナトリウム(
2×500ml)で洗浄して透明な淡褐色溶液を得た。 溶剤をストリッピング除去して結晶固体と油状液との混
合物を得、次いでこれを60/80石油(1リットル)
で0℃にてトリチル化し、さらに濾過して315gの1
−(4−クロルベンジル)−4,4,6−トリメチルシ
クロヘキシ−1−エン−3−オンを結晶質の白色固体と
して得た。融点76〜77℃。
(b) 1-(4-chlorobenzyl)-4,
Preparation of 4,6-trimethylcyclohex-1-en-3-one Sodium dichromate (281 g, 0.9
A solution of 43 mol) of 1-(4-
(chlorobenzyl)-4,4,6-trimethylcyclohex-2-en-1-ol in ether. The reaction mixture was then heated to 50-60° C. over 3-4 hours, then cooled and quenched with water (2 liters) and diethyl ether (1 liter). The phases were separated and the organic phase was dissolved in 20% (w/v) sodium hydroxide (
2 x 500 ml) to give a clear light brown solution. Stripping off the solvent gave a mixture of crystalline solid and oil, which was then poured into 60/80 petroleum (1 liter).
Tritylated at 0°C, further filtered, and 315 g of 1
-(4-chlorobenzyl)-4,4,6-trimethylcyclohex-1-en-3-one was obtained as a crystalline white solid. Melting point 76-77°C.

【0020】実施例5 1−(クロルベンジル)−1,2−エポキシ−4,4,
6−トリメチルシクロヘキサン−3−オンの製造(n=
1、  R=4−Cl、  R1 =R2 =R3 =
CH3 、  R6 およびR7 =−O−、  R8
 =H)上記実施例4で得られた1−(クロルベンジル
)−4,4,6−トリメチルシクロヘキサン−3−オン
(315g、1.2モル)をメタノール(1500ml
)に添加し、混合物を40℃まで加温して透明な黄色溶
液を得た。次いで、この溶液を10℃まで冷却し、水酸
化ナトリウム水溶液(水112ml中25g)を10分
間かけて添加した。反応混合物の温度を15〜20℃に
維持しながら30%(w/v)の過酸化水素水溶液(1
38ml、1.2モル)を30分間かけて添加し、次い
で混合物を1晩攪拌した。次いで、さらに30mlを添
加し、混合物を2.5時間攪拌した。次いで反応混合物
を減圧下で濃縮すると共に、水(2リットル)およびジ
エチルエーテル(1.5リットル)で希釈した。次いで
水層をジエチルエーテル(2×0.5リットル)で抽出
し、脱水し、さらに溶剤をフラッシュ除去して1−(4
−クロルベンジル)−1,2−エポキシ−4,4,6−
トリメチルシクロヘキサン−3−オンを結晶質の白色固
体(271g)として得た。融点58〜59℃。
Example 5 1-(chlorobenzyl)-1,2-epoxy-4,4,
Preparation of 6-trimethylcyclohexan-3-one (n=
1, R=4-Cl, R1=R2=R3=
CH3, R6 and R7 = -O-, R8
=H) 1-(chlorobenzyl)-4,4,6-trimethylcyclohexan-3-one (315 g, 1.2 mol) obtained in Example 4 above was mixed with methanol (1500 ml).
) and the mixture was warmed to 40° C. to give a clear yellow solution. The solution was then cooled to 10° C. and an aqueous sodium hydroxide solution (25 g in 112 ml water) was added over 10 minutes. A 30% (w/v) aqueous hydrogen peroxide solution (1
38 ml, 1.2 mol) was added over 30 minutes and the mixture was then stirred overnight. A further 30 ml was then added and the mixture was stirred for 2.5 hours. The reaction mixture was then concentrated under reduced pressure and diluted with water (2 liters) and diethyl ether (1.5 liters). The aqueous layer was then extracted with diethyl ether (2 x 0.5 liters), dried and the solvent was flashed off to give 1-(4
-chlorobenzyl)-1,2-epoxy-4,4,6-
Trimethylcyclohexan-3-one was obtained as a crystalline white solid (271 g). Melting point 58-59°C.

【0021】実施例6 1−(4−クロルベンジル)−2−ヒドロキシ−4,4
,6−トリメチルシクロヘキシ−1−エン−3−オンの
製造 (n=1、  R=4−Cl、  R1 =R2 =R
3 =CH3 、  R6 およびR7 =単一C−C
結合、  R8 =OH) フレーク状の水酸化カリウム(30.4g、3当量)を
、t−ブタノール(200ml)における上記実施例5
で得られた1−(4−クロルベンジル)−1,2−エポ
キシ−4,4,6−トリメチルシクロヘキサン−3−オ
ン(43g、0.154モル)の溶液に40〜50℃に
て添加し、次いで混合物を3時間にわたり還流させた。 ガスクロマトグラフィーは所望の1−(4−クロルベン
ジル)−2−ヒドロキシ−4,4,6−トリメチルシク
ロヘキシ−1−エン−3−オンの存在を示し、その小部
分を特性化すべく油状物として単離した。
Example 6 1-(4-chlorobenzyl)-2-hydroxy-4,4
, 6-trimethylcyclohex-1-en-3-one (n=1, R=4-Cl, R1=R2=R
3 = CH3, R6 and R7 = single C-C
bond, R8=OH) Potassium hydroxide in flake form (30.4 g, 3 eq.) was prepared from Example 5 above in t-butanol (200 ml).
was added to the solution of 1-(4-chlorobenzyl)-1,2-epoxy-4,4,6-trimethylcyclohexan-3-one (43 g, 0.154 mol) obtained at 40 to 50 °C. , then the mixture was refluxed for 3 hours. Gas chromatography showed the presence of the desired 1-(4-chlorobenzyl)-2-hydroxy-4,4,6-trimethylcyclohex-1-en-3-one and an oil was prepared to characterize a small portion of it. isolated as.

Claims (8)

【特許請求の範囲】[Claims] 【請求項1】  一般式: 【化1】 〔式中、nは0〜5の整数を示し;  各Rはハロゲン
原子、ニトロ、シアノ、ヒドロキシル、アルキル、ハロ
アルキル、アルコキシ、ハロアルコキシ、アミノ、アル
キルアミノ、ジアルキルアミノ、アルコキシカルボニル
、カルボキシル、アルカノイル、アルキルチオ、アルキ
ルスルフィニル、アルキルスルホニル、カルバモイル、
アルキルアミド、シクロアルキルもしくはフェニル基を
示し;  R1 、R2 およびR3 は独立して水素
原子もしくはアルキル基を示し;  R6 およびR7
 は一緒になって単一の炭素−炭素結合またはエポキシ
基を示し;  R8 は水素原子もしくはヒドロキシル
基を示し;  ただしR6 とR7とが一緒になってエ
ポキシ基を示せばR8 は水素原子を示す〕の化合物。
[Claim 1] General formula: [Formula 1] [wherein n represents an integer of 0 to 5; each R is a halogen atom, nitro, cyano, hydroxyl, alkyl, haloalkyl, alkoxy, haloalkoxy, amino, alkyl Amino, dialkylamino, alkoxycarbonyl, carboxyl, alkanoyl, alkylthio, alkylsulfinyl, alkylsulfonyl, carbamoyl,
represents an alkylamide, cycloalkyl or phenyl group; R1, R2 and R3 independently represent a hydrogen atom or an alkyl group; R6 and R7
together represent a single carbon-carbon bond or an epoxy group; R8 represents a hydrogen atom or a hydroxyl group; however, if R6 and R7 together represent an epoxy group, R8 represents a hydrogen atom] compound.
【請求項2】  R1 、R2 およびR3 が独立し
て水素原子もしくはC1−4 アルキル基を示す請求項
1に記載の化合物。
2. The compound according to claim 1, wherein R1, R2 and R3 independently represent a hydrogen atom or a C1-4 alkyl group.
【請求項3】  R1 、R2 およびR3 が独立し
て水素原子もしくはメチル基を示す請求項1または2に
記載の化合物。
3. The compound according to claim 1 or 2, wherein R1, R2 and R3 independently represent a hydrogen atom or a methyl group.
【請求項4】  Rがハロゲン原子を示す請求項1〜3
のいずれかに記載の化合物。
4. Claims 1 to 3, wherein R represents a halogen atom.
A compound according to any one of.
【請求項5】  nが1であり、Rが塩素原子を示し、
R1 およびR2 が両者とも水素原子を示しまたは両
者ともメチル基を示し、R3 が水素原子もしくはメチ
ル基を示す請求項1〜4のいずれかに記載の化合物。
5. n is 1, R represents a chlorine atom,
5. The compound according to claim 1, wherein R1 and R2 both represent a hydrogen atom or both represent a methyl group, and R3 represents a hydrogen atom or a methyl group.
【請求項6】  (a)一般式: 【化2】 〔式中、n、R、R1 、R2 およびR3 は上記の
意味を有する〕の化合物を酸の存在下に酸化剤と反応さ
せて、R6 とR7 とが一緒になって単一の炭素−炭
素結合を示しかつR8 が水素原子を示す式Iの化合物
を生成させ;(b)所望ならば、工程(a)で生成され
た式Iの化合物を塩基の存在下に過酸化水素と反応させ
て、R6 とR7 とが一緒になってエポキシ基を示し
かつR8 が水素原子を示す式Iの化合物を生成させ; (c)所望ならば、工程(b)で生成された式Iの化合
物を極性溶剤の存在下に一般式: MOR5                     
  (III)〔式中、R5 は水素原子またはアルキ
ルもしくはシクロアルキル基を示し、Mはアルカリ金属
原子を示す〕の化合物と反応させて、R6 とR7 と
が一緒になって単一の炭素−炭素結合を示しかつR8 
がヒドロキシル基を示す式Iの化合物を生成させること
を特徴とする請求項1〜5のいずれかに記載の式Iを有
する化合物の製造方法。
6. (a) General formula: [In the formula, n, R, R1, R2 and R3 have the above meanings] is reacted with an oxidizing agent in the presence of an acid, R6 and R7 together represent a single carbon-carbon bond and R8 represents a hydrogen atom; (b) if desired, the compound of formula I produced in step (a); react with hydrogen peroxide in the presence of a base to form a compound of formula I in which R6 and R7 together represent an epoxy group and R8 represents a hydrogen atom; (c) if desired; , the compound of formula I produced in step (b) is converted into a compound of general formula: MOR5 in the presence of a polar solvent.
(III) [In the formula, R5 represents a hydrogen atom or an alkyl or cycloalkyl group, and M represents an alkali metal atom] to combine R6 and R7 into a single carbon-carbon indicates a bond and R8
Process for the preparation of compounds of formula I according to any of claims 1 to 5, characterized in that a compound of formula I is produced in which represents a hydroxyl group.
【請求項7】  工程(a)における酸化剤がアルカリ
金属重クロム酸塩である請求項6に記載の方法。
7. The method of claim 6, wherein the oxidizing agent in step (a) is an alkali metal dichromate.
【請求項8】  工程(c)における極性溶剤が一般式
:R5 OH                   
   (IV)〔式中、R5 は請求項6に記載の意味
を有する〕の化合物である請求項6に記載の方法。
8. The polar solvent in step (c) has the general formula: R5 OH
7. The method according to claim 6, which is a compound of (IV) in which R5 has the meaning as defined in claim 6.
JP24656191A 1990-09-03 1991-09-02 Cyclohexanone derivative Expired - Fee Related JP3241760B2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB909019193A GB9019193D0 (en) 1990-09-03 1990-09-03 Cyclohexenol derivatives
GB9019193.3 1990-09-03
GB9019194.1 1990-09-03
GB909019192A GB9019192D0 (en) 1990-09-03 1990-09-03 Cyclohexenone derivatives
GB909019194A GB9019194D0 (en) 1990-09-03 1990-09-03 Cyclohexanone derivatives
GB9019192.5 1990-09-03

Publications (2)

Publication Number Publication Date
JPH04316531A true JPH04316531A (en) 1992-11-06
JP3241760B2 JP3241760B2 (en) 2001-12-25

Family

ID=27265248

Family Applications (1)

Application Number Title Priority Date Filing Date
JP24656191A Expired - Fee Related JP3241760B2 (en) 1990-09-03 1991-09-02 Cyclohexanone derivative

Country Status (9)

Country Link
US (1) US5200535A (en)
EP (1) EP0474301B1 (en)
JP (1) JP3241760B2 (en)
KR (1) KR100218139B1 (en)
BR (1) BR9103785A (en)
CA (1) CA2050466A1 (en)
DE (1) DE69115608T2 (en)
HU (1) HU214552B (en)
IL (1) IL99253A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020034258A (en) * 2000-10-31 2002-05-09 최원철 Novel compound isolated from Symphyocladia latiuscula and process for preparation thereof
US7914793B2 (en) 1997-01-29 2011-03-29 Shozo Koyama Method for producing an antigenic substance and antibody

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5808139A (en) * 1992-04-21 1998-09-15 Ligand Pharmaceuticals Incorporated Non-steroid progesterone receptor agonist and antagonist and compounds and methods
WO1994024080A1 (en) * 1993-04-16 1994-10-27 Ligand Pharmaceuticals Inc. Progesterone receptor agonist and antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863505A (en) * 1985-09-12 1989-09-05 Kureha Kagaku Kogyo Kabushiki Kaisha Novel derivative of azole, and agricultural and horticultural composition containing the same as an active incredient
JPH0625140B2 (en) * 1986-11-10 1994-04-06 呉羽化学工業株式会社 Novel azole derivative, method for producing the same and agricultural / horticultural drug of the derivative
CA1335294C (en) * 1988-08-31 1995-04-18 Paul Howard Briner Fungicidal compositions

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7914793B2 (en) 1997-01-29 2011-03-29 Shozo Koyama Method for producing an antigenic substance and antibody
KR20020034258A (en) * 2000-10-31 2002-05-09 최원철 Novel compound isolated from Symphyocladia latiuscula and process for preparation thereof

Also Published As

Publication number Publication date
DE69115608T2 (en) 1996-09-19
EP0474301B1 (en) 1995-12-20
HU912841D0 (en) 1992-01-28
US5200535A (en) 1993-04-06
CA2050466A1 (en) 1992-03-04
HU214552B (en) 1998-08-28
IL99253A (en) 1995-06-29
JP3241760B2 (en) 2001-12-25
DE69115608D1 (en) 1996-02-01
HUT58678A (en) 1992-03-30
KR920006266A (en) 1992-04-27
KR100218139B1 (en) 1999-09-01
BR9103785A (en) 1992-05-19
EP0474301A2 (en) 1992-03-11
EP0474301A3 (en) 1992-07-08

Similar Documents

Publication Publication Date Title
IL201407A (en) 1-aryl-3-sulfonyl-4,5-dihydro-1h-pyrazole-carboxylic acid and esters thereof
HU207841B (en) Process for producing biphenyl-carbonitrils
EP1773783B1 (en) Method for preparing n-piperidino-1,5-diphenylpyrazole-3-carboxamide derivatives
JPH01265045A (en) Cyclopropane derivative
US5142061A (en) Process for the preparation of cyclopentane derivatives
JP3241760B2 (en) Cyclohexanone derivative
US5869684A (en) Method for producing pyrazolinone compounds
SK280894B6 (en) 1,1,1-TRIFLUORO-2-PROPENE DERIVATIVES AND METHOD OF THEIR PRODUCTION
JPH023639A (en) Production of 3, 3-diarylacrylamide
KR19990008411A (en) Improvement method of 4-hydroxy-2-pyrrolidone
JPH02289563A (en) Improved process for producing ortho-carboxypyridyl- and ortho-carboxyquinolylimidazolinones
JP4512100B2 (en) Process for producing substituted benzopyran compounds
JP2808322B2 (en) Process for producing cyclopentene, cyclopentane and cyclohexane derivatives
JP3078053B2 (en) Cyclopentane derivative
JP3162434B2 (en) Cyclohexenol derivative
JPH0692950A (en) Method for producing epoxy compound
JP2896949B2 (en) Method for producing 1- (4-acylphenyl) azoles
US4267388A (en) Process for producing ethynylbenzenes
JP2986003B2 (en) 2-Alkyl-3-styryloxiranecarboxylic acid ester and method for producing the same
JP3013114B2 (en) Method for producing cyclic ketones
JPH06228103A (en) New octahydroacridine derivative and its production
HU193454B (en) Process for producing 3-phenyl-butyraldehyde derivatives
US5262543A (en) Process for the preparation of cyclopentane derivatives
JPH07215946A (en) Production of 2-cyanoimidazole compound
KR100365526B1 (en) Synthesis of the bicyclo[3.3.1]nonane structure

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees